These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15871365)

  • 1. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
    Amarapurkar DN; Rane P
    J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
    Sawant P; Das HS; Desai N; Kalokhe S; Patil S
    J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
    Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled trial of itopride in functional dyspepsia.
    Holtmann G; Talley NJ; Liebregts T; Adam B; Parow C
    N Engl J Med; 2006 Feb; 354(8):832-40. PubMed ID: 16495395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of itopride in the symptoms of functional dyspepsia in Russia: results of a phase IV prospective open-label multicenter clinical trial].
    Kas'ianenko VI; Denisov NL; Vasil'ev IuV
    Ter Arkh; 2014; 86(8):35-41. PubMed ID: 25306742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia.
    Shenoy KT; Veenasree ; Leena KB
    J Indian Med Assoc; 2003 Jun; 101(6):387-8. PubMed ID: 14579989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia].
    Chen SY; Wang JY; Zhu CW; Yuan YZ; Zou B; Xia L; Liu JY; Xu HW; Zhang SZ; Wang Q; Xie XJ; Zhao ZQ; Lin L; Hu NZ; Xu JM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):165-8. PubMed ID: 15132875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
    Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.
    Sun J; Yuan YZ; Holtmann G
    Clin Drug Investig; 2011 Dec; 31(12):865-75. PubMed ID: 22035464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabeto plus: a valuable drug for managing functional dyspepsia.
    Ghosh A; Halder S; Mandal S; Mandal A; Basu M; Dabholkar P
    J Indian Med Assoc; 2008 Nov; 106(11):752-4. PubMed ID: 19368103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study.
    Hallerbäck BI; Bommelaer G; Bredberg E; Campbell M; Hellblom M; Lauritsen K; Wienbeck M; Holmgren LL
    Aliment Pharmacol Ther; 2002 May; 16(5):959-67. PubMed ID: 11966505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study.
    Walwaikar PP; Kulkarni SS; Bargaje RS
    J Indian Med Assoc; 2005 Dec; 103(12):708-9. PubMed ID: 16821670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itopride therapy for functional dyspepsia: a meta-analysis.
    Huang X; Lv B; Zhang S; Fan YH; Meng LN
    World J Gastroenterol; 2012 Dec; 18(48):7371-7. PubMed ID: 23326147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia.
    Cho KH; Choi YK; Kang JH; Choi HG; Yong CS; Park YJ
    Int J Pharm; 2010 Nov; 400(1-2):145-52. PubMed ID: 20826201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies.
    Seno H; Nakase H; Chiba T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():32-6. PubMed ID: 15943844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo.
    Tsubouchi T; Saito T; Mizutani F; Yamauchi T; Iwanaga Y
    J Pharmacol Exp Ther; 2003 Aug; 306(2):787-93. PubMed ID: 12724347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
    Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y; Yoshida N; Kaneko H
    J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.